Energy & metabolic
Measured in µIU/mL.
Fasting insulin measures how much insulin the pancreas is releasing to hold blood glucose steady after an overnight fast. It is the earliest widely available signal of insulin resistance, because the body defends a normal glucose level for years by producing progressively more insulin before glucose itself begins to rise. A person can therefore have a completely normal fasting glucose and HbA1c while already requiring two or three times the normal amount of insulin to achieve it. That period — normal glucose, high insulin — is where most of the reversible metabolic damage accumulates, and it is invisible on the standard checkup panel, which measures glucose but not insulin. Fasting insulin is the marker that makes it visible, typically many years before a diabetes diagnosis becomes possible.
Insulin rises years before glucose does, so a normal fasting sugar does not exclude insulin resistance.
Typical laboratory ranges extend to about 25 µIU/mL, wide enough to call substantial resistance "normal".
It is one of the most responsive markers on a metabolic panel, often moving measurably within twelve weeks.
A high fasting insulin means the pancreas is working hard to keep glucose normal — the defining feature of insulin resistance. It commonly accompanies abdominal fat, raised triglycerides, low HDL, fatty liver and afternoon energy crashes. Because it precedes rising glucose by years, it is the most actionable early finding on a metabolic panel.
A low fasting insulin alongside normal glucose indicates good insulin sensitivity and is a favourable result. Low insulin together with high glucose is a different and more serious pattern, suggesting the pancreas is no longer producing enough, and needs prompt medical assessment.
| Band | Value |
|---|---|
| Optimal | 2 – 6 µIU/mL |
| Early insulin resistance | 6 – 10 µIU/mL |
| Insulin resistance likely | > 10 µIU/mL |
| Typical laboratory reference range | up to ~25 µIU/mLWide enough to include substantial resistance — this is why "normal" is misleading here |
Laboratory intervals vary. Interpret with a physician.
India has more adults with prediabetes (15.3%) than with diabetes (11.4%), and 42% of those with already-high blood sugar did not know it. Indians also develop insulin resistance at lower BMIs than Western populations, so a normal weight is not reassurance. Fasting insulin is not part of any standard Indian checkup package.
HOMA-IR is a calculated index that combines fasting glucose and fasting insulin into a single number describing how resistant the body has become to its own insulin.
HbA1c measures the proportion of haemoglobin in your red blood cells that has sugar attached to it.
ApoB, or apolipoprotein B, is a protein that sits on the surface of every cholesterol particle capable of lodging in an artery wall.
hs-CRP is a high-sensitivity measurement of C-reactive protein, a substance the liver releases in response to inflammation.
An elevated fasting insulin is a reason for an unhurried conversation with a physician about diet, activity and follow-up testing, not an emergency. Excessive thirst, frequent urination, unexplained weight loss or blurred vision should be assessed promptly regardless of the insulin result.
Checkup packages are built around diagnosing established disease at scale, and glucose and HbA1c are cheaper and sufficient for that purpose. Fasting insulin detects the years-long phase before disease, which the diagnostic framework those packages serve is not designed to catch.
Eight to twelve hours, water permitted. Insulin responds sharply to food, so a shortened fast can raise the result substantially and make it uninterpretable. Hard exercise and alcohol in the preceding twenty-four hours also move it.
Frequently, yes — it is one of the more responsive markers on a metabolic panel. Reducing refined carbohydrate, losing visceral fat, adding resistance training and improving sleep all lower it, often measurably within twelve weeks. That responsiveness is why it is worth retesting.
The programme
Peak Brain draws a full blood and urine panel at your home, has a licensed physician read every marker together rather than one at a time, and turns what they find into a ranked 90-day protocol with a retest at the end.
Authorship & review
Written by the Peak Brain clinical team. Assigned clinical reviewer: Dr. Alfia Kaki, MD, PGC — review pending; this page has not yet been signed off.
Published . Last updated .
This page is general health information, not medical advice, diagnosis or treatment. Reference ranges vary between laboratories. Never delay or disregard advice from a qualified health professional because of something you read here. If you think you may have a medical emergency, call your local emergency number.